Kineta Inc (KA): Bathi mangsa ngarep

Kineta Bio - logo grafis emiten KA

Kineta, Inc. (KA) is developing innovative immunotherapy to combat "cold" tumors, positioning itself as a potential acquisition target for pharma behemoths. The GURU.Markets terminal provides a future profit trajectory, where the indicator stands at , helping to distinguish genuine business growth from speculation. Patent protection for its antibodies creates a robust barrier for competitors, although the project's success depends on the effectiveness of reducing immunosuppression and the influx of investment.

KA: Prakiraan bathi perusahaan Kineta, Inc. 04.07.2022 - 15.11.2026

Rincian analitis perusahaan Kineta, Inc.

Analisis dhasar perusahaan:KA, Kineta Bio
Barang utama Kineta Corp

The reliability of equity assets is determined by a business's ability to generate future cash flow. This indicator measures the discounted value of expected earnings, reflecting market expectations for margins and expansion rates. For Kineta, Inc. (KA), calculations are complicated by geopolitical barriers that block international oncology drug trials and slow the registration of therapies. An analysis of future profit valuation helps identify stagnation risks resulting from scientific isolation. An upward trend in this future profit valuation confirms the fundamental stability of Kineta, Inc. (KA).

Perusahaan pesaing

Bathi sing dikarepake NantKwest|Bathi resik sing dikarepake Immunocore IMCR|Proyeksi bathi mangsa ngarep JANX|Arcus Biosciences, Inc. (RCUS) - Proyeksi bathi resik|Zymeworks Inc - Bathi mangsa ngarep|Tango Therapeutics, Inc. (TNGX) - Bathi resik sing dikarepake|IOVA: Bathi mangsa ngarep|Penghasilan resik sing dikarepake IMTX (Immatics)|XNCR: Proyeksi bathi mangsa ngarep|CMPX - Prakiraan bathi perusahaan|Bathi sing dikarepake replimune.com|Bathi mangsa ngarep lyell.com (LYEL)|Bathi sing dikarepake Innate Pharma SA (IPHA)|Bathi mangsa ngarep Pyxis PYXS|Compugen Ltd - Bathi mangsa ngarep|Proyeksi bathi mangsa ngarep IO Biotech Inc. IOBT|STRO - Bathi sing dikarepake|INKT (minktherapeutics.com) - Prakiraan bathi resik|werewolftx.com (HOWL) - Bathi sing dikarepake|Bathi resik sing dikarepake Immix Biopharma, Inc. (IMMX)|Bathi mangsa ngarep ALXO|CUE (Cue Biopharma, Inc.) - Bathi resik mangsa ngarep|Bathi mangsa ngarep PDSB (PDS Biotechnology)|Bathi resik mangsa ngarep SONN|Proyeksi bathi mangsa ngarep MAIA (MAIA Biotechnology, Inc.)|Penghasilan resik sing dikarepake LIMN|Lava Tx - Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake NextCure Corporation|Leap Tx (LPTX) - Bathi sing dikarepake|Intensity Therapeutics Inc - Penghasilan resik sing dikarepake|SNSE (Sensei Bio) - Proyeksi bathi mangsa ngarep|Proyeksi bathi mangsa ngarep Theriva Biologics Inc|Bathi sing dikarepake gritstonebio.com (GRTS)|NEXI: Bathi forward|Turnstone Biologics Corp. - Bathi mangsa ngarep|Vaccinex (VCNX) - Bathi resik sing dikarepake|Harpoon Therapeutics, Inc. - Proyeksi bathi mangsa ngarep